The Watanabe heritable hyperlipidemic (WHHL) rabbit, its characteristics and history of development: A tribute to the late Dr. Yoshio Watanabe

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 1-7

  Shiomi, Masashi ^a   Ito, Takashi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Hypercholesterolemia; LDL receptor deficiency; WHHL rabbit

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER TRANSFER PROTEIN; COMPACTIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PRAVASTATIN; SQUALENE SYNTHASE INHIBITOR;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BREEDING; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG POTENTIATION; HEART INFARCTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; INCIDENCE; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RABBIT; RAT; REVIEW; SPECIES DIFFERENCE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOMEDICAL RESEARCH; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPOPROTEINS; MYOCARDIAL INFARCTION; RABBITS; RECEPTORS, LDL;

EID: 70350573441     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.024     Document Type: Review

References (69)

1. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis 36 (1980) 261-268
2. Goldstein J.L., Kita T., and Brown M.S. Defective lipoprotein receptors and atherosclerosis: lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med 309 (1983) 288-296
3. Watanabe Y. Studies on characteristics of spontaneously hyperlipemic rabbits and development of the strains with such property. Bull Azabu Vet Coll 2 (1977) 99-124 (in Japanese)
4. Watanabe Y., Ito T., and Kondo T. Breeding of a rabbit strain of hyperlipidemia and characteristics of the strain. Exp Anim 26 (1977) 35-42 (in Japanese)
5. Goldstein J.L., and Brown M.S. Binding and degradation of low density lipoproteins by cultured human fibroblasts, comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem 249 (1974) 5153-5162
6. Endo A., Kuroda M., and Tsujita Y. ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium. J Antibiot (Tokyo) 29 (1976) 1346-1348
7. Tanzawa K., Shimada Y., Kuroda M., Tsujita Y., Arai M., and Watanabe Y. WHHL-rabbit: a low density lipoprotein receptor-deficient animal model for familial hypercholesterolemia. FEBS Lett 118 (1980) 81-84
8. Kita T., Brown M.S., Watanabe Y., and Goldstein J.L. Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci USA 78 (1981) 2268-2272
9. Attie A.D., Pittman R.C., Watanabe Y., and Steinberg D. Low density lipoprotein receptor deficiency in cultured hepatocytes of the WHHL rabbit. J Biol Chem 256 (1981) 9789-9792
10. Havel R.J., Kita T., Kotite L., et al. Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. Arteriosclerosis 2 (1982) 467-474
11. Kita T., Goldstein J.L., Brown M.S., et al. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc Natl Acad Sci USA 79 (1982) 3623-3627
12. Kita T., Brown M.S., Bilheimer D.W., and Goldstein J.L. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits. Proc Natl Acad Sci USA 79 (1982) 5693-5697
13. Dietschy J.M., Kita T., Suckling K.E., Goldstein J.L., and Brown M.S. Cholesterol synthesis in vivo and in vitro in the WHHL rabbit, an animal with defective low density lipoprotein receptors. J Lipid Res 24 (1983) 469-480
14. Schneider W.J., Brown M.S., and Goldstein J.L. Kinetic defects in the processing of the low density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with familial hypercholesterolemia. Mol Biol Med 1 (1983) 353-367
15. Yamamoto T., Bishop R.W., Brown M.S., Goldstein J.L., and Russell D.W. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. Science 232 (1986) 1230-1237
16. Bilheimer D.W., Watanabe Y., and Kita T. Impaired receptor-mediated catabolism of low density lipoprotein in the WHHL rabbit, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci USA 79 (1982) 3305-3309
17. Pittman R.C., Carew T.E., Attie A.D., et al. Receptor-dependent and receptor-independent degradation of low density lipoprotein in normal rabbits and in receptor-deficient mutant rabbits. J Biol Chem 257 (1982) 7994-8000
18. Hornick C.A., Kita T., Hamilton R.L., Kane J.P., and Havel R.J. Secretion of lipoproteins from the liver of normal and Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci USA 80 (1983) 6096-6100
19. Son Y.C., and Zilversmit D.B. Increased lipid transfer activities in hyperlipidemic rabbit plasma. Arteriosclerosis 6 (1986) 345-351
20. Nakamura M., Taniguchi S., Ishida B.Y., Kobayashi K., and Chan L. Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice, role of apoB mRNA editing in lipoprotein phenotype expression. Arterioscler Thromb Vasc Biol 18 (1998) 747-755
21. Ishibashi S., Goldstein J.L., Brown M.S., Herz J., and Buma D.K. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 93 (1994) 1885-1893
22. Agellon L.B., Walsh A., Hayek T., et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 266 (1991) 10796-10801
23. Kozarsky K.F., Bonen D.K., Giannoni F., et al. Hepatic expression of the catalytic subunit of the apolipoprotein B mRNA editing enzyme (apobec-1) ameliorates hypercholesterolemia in LDL receptor-deficient rabbits. Hum Gene Ther 7 (1996) 943-957
24. Hilano K., Min J., Funahashi T., and Davidson N.O. Cloning and characterization of the rat apobec-1 gene: a comparative analysis of gene structure and promoter usage in rat and mouse. J Lipid Res 38 (1997) 1103-1119
25. Li X., Catalina F., Grundy S.M., and Patel S. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48 relative to B-100-containing lipoproteins. J Lipid Res 37 (1996) 210-220
26. González-Navarro H., Nong Z., Amar M.J., et al. The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice. J Biol Chem 279 (2004) 45312-45321
27. Buja L.M., Kita T., Goldstein J.L., Watanabe Y., and Brown M.S. Cellular pathology of progressive atherosclerosis in the WHHL rabbit, an animal model of familial hypercholesterolemia. Arteriosclerosis 3 (1983) 87-101
28. Cybulsky M.I., and Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251 (1991) 788-791
29. Rosenfeld M.E., Tsukada T., Gown A.M., and Ross R. Fatty streak initiation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 7 (1987) 9-23
30. Rosenfeld M.E., Tsukada T., Chait A., et al. Fatty streak expansion and maturation in Watanabe heritable hyperlipidemic and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 7 (1987) 24-34
31. Takano T., Amanuma K., Kimura J., Kanaseki T., and Ohkuma S. Involvement of macrophages in accumulation and elimination of cholesterol ester in atherosclerotic aorta. Acta Histochem Cytochem 19 (1986) 135-143
32. Tsukada T., Rosenfeld M., Ross R., and Gown A.M. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabe and fat-fed rabbit. Arteriosclerosis 6 (1986) 601-613
33. Nakazato K., Ishibashi T., Shindo J., Shiomi M., and Maruyama Y. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions. Am J Pathol 149 (1996) 1831-1838
34. Hiltunen T.P., Luoma J.S., Nikkari T., and YlaHerttuala S. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation 97 (1998) 1079-1086
35. Mowri H., Ohkuma S., and Takano T. Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions. Biochim Biophys Acta 963 (1988) 208-214
36. Boyd H.C., Gown A.M., Wolfbaur G., and Chait A. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. Am J Pathol 135 (1989) 815-825
37. Frank J.S., and Fogelman A.M. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J Lipid Res 30 (1989) 967-968
38. Nakajima K., Nakano T., and Tanaka A. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin Chim Acta 367 (2006) 36-47
39. Amanuma K., Kanaseki T., Ikeuchi Y., Ohkuma S., and Takano T. Studies on fine structure and location of lipids in quick-freeze replicas of atherosclerotic aorta of WHHL rabbits. Virchows Arch A 410 (1986) 231-238
40. Shiomi M., Ito T., Tsukada T., Yata T., and Ueda M. Cell composition of coronary and aortic atherosclerotic lesions in WHHL rabbits differ. Arterioscler Thromb 14 (1994) 931-937
41. Shiomi M., Ito T., Tsukada T., et al. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques: effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits. Arterioscler Theromb Vasc Biol 15 (1995) 1938-2144
42. Fukumoto Y., Libby P., Rabkin E., et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 103 (2001) 993-999
43. Shiomi M., Ito T., Hirouchi Y., and Enomoto M. Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins. Atherosclerosis 157 (2001) 75-84
44. Shiomi M., Yamada S., and Ito T. Atheroma stabilizing effects of simvastatin due to depression of macrophages or lipid accumulation in the atheromatous plaques of coronary atherosclerosis-prone WHHL rabbits. Atherosclerosis 178 (2005) 287-294
45. Shiomi M., Yamada S., Amano Y., Nishimoto T., and Ito T. Lapaquistat acetate (TAK-475), a squalene synthase inhibitor, changes macrophage/lipid-rich coronary plaques of WHHLMI rabbits into fibrous lesions. Br J Pharmacol 154 (2008) 949-957
46. Aikawa M., Rabkin E., Okada Y., et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheromas: a potential mechanism of lesion stabilization. Circulation 97 (1998) 2433-2444
47. Watanabe Y., Ito T., and Shiomi M. The effect of selective breeding on the development of coronary atherosclerosis in WHHL rabbits, an animal model for familial hypercholesterolemia. Atherosclerosis 56 (1985) 71-79
48. Shiomi M., Ito T., Shiraishi M., and Watanabe Y. Inheritability of atherosclerosis and the role of lipoproteins as risk factors in the development of atherosclerosis in WHHL rabbits: risk factors related to coronary atherosclerosis are different from those related to aortic atherosclerosis. Atherosclerosis 96 (1992) 43-52
49. Ito T., and Shiomi M. Cerebral atherosclerosis occurs spontaneously in homozygous WHHL rabbits. Atherosclerosis 156 (2001) 57-66
50. Shiomi M., Ito T., Yamada S., Kawashima S., and Fan J. Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit). Arterioscler Thromb Vasc Biol 23 (2003) 1239-1244
51. Van der Wall A.C., Becker A.E., Van der Loos C.M., and Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 104 (2001) 365-372
52. Shiomi M., and Fan J. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries. Curr Opin Lipidol 19 (2008) 631-636
53. Ito T., Yamada S., and Shiomi M. Progression of coronary atherosclerosis relates to the onset of myocardial infarction in an animal model of spontaneous myocardial infarction (WHHLMI rabbits). Exp Anim 53 (2004) 339-346
54. Shiomi M., Yamada S., Matsukawa A., Itabe H., and Ito T. Invasion of atheromatous plaques into tunica media causes coronary outward remodeling in WHHLMI rabbits. Atherosclerosis 198 (2008) 287-293
55. Liew T.V., and Ray K.K. Intensive statin therapy in acute coronary syndromes. Curr Atheroscler Rep 10 (2008) 158-163
56. Watanabe Y., Ito T., Saeki M., et al. Hypolipidemic effects of CS-500 (ML-236B) in WHHL-rabbit, a heritable animal model for hyperlipidemia. Atherosclerosis 38 (1981) 27-31
57. Tsujita Y., Kuroda M., Shimada Y., et al. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta 877 (1986) 50-60
58. Watanabe Y., Ito T., Shiomi M., et al. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim Biophys Acta 960 (1988) 294-302
59. Kita T., Nagano Y., Yokode M., et al. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84 (1987) 5928-5931
60. Carew T.E., Schwenke D.C., and Steinberg D. Antiatherogenic effect of probucol unrelated to its hypercholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci USA 84 (1987) 7725-7729
61. Steen H., Lima J.A., Chatterjee S., et al. High-resolution three-dimensional aortic magnetic resonance angiography and quantitative vessel wall characterization of different atherosclerotic stages in a rabbit model. Invest Radiol 42 (2007) 614-621
62. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. J Nucl Med 45 (2004) 1245-1250
63. Iwata A., Miura S., Imaizumi B., and Saku K. Measurement of atherosclerotic plaque volume in hyperlipidemic rabbit aorta by intravascular ultrasound. J Cardiol 50 (2007) 229-234
64. Shen J., Herderick E., Cornhill J.F., et al. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J Clin Invest 98 (1996) 2201-2208
65. Brousseau M.E., Kauffman R.D., Herderick E.E., et al. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptor in transgenic rabbits. Arterioscler Thromb Vasc Biol 20 (2000) 450-458
66. Fan J., Challah M., Shimoyamada H., et al. Defects of the LDL receptor in WHHL transgenic rabbits lead to a marked accumulation of plasma lipoprotein(a). J Lipid Res 41 (2000) 1004-1012
67. Koike T., Liang J., Wang X., et al. Overexpression of lipoprotein lipase in transgenic Watanabe heritable hyperlipidemic rabbits improves hyperlipidemia and obesity. J Biol Chem 279 (2004) 7521-7529
68. Sun H., Koike T., Ichikawa T., et al. C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance. Am J Pathol 167 (2005) 1139-1148
69. Fan J., and Watanabe T. Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol Ther 99 (2003) 261-282